HVIVO PLC Logo

HVIVO PLC

HVO | IL

Overview

Corporate Details

ISIN(s):
GB00B9275X97
LEI:
213800VT5KBM7JLIV118
Country:
United Kingdom
Address:
QUEEN MARY BIOENTERPRISES INNOVATION CENTRE, E1 2AX LONDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

hVIVO PLC is a specialist contract research organization (CRO) and a world leader in human challenge clinical trials for testing infectious and respiratory disease vaccines and therapeutics. The company provides end-to-end services, designing and conducting trials where volunteers are safely exposed to a pathogen to accelerate the evaluation of new medical interventions. Its expertise covers a wide range of well-established challenge models for diseases such as Influenza, RSV, COVID-19, hMPV, and Malaria. Leveraging state-of-the-art quarantine facilities, proprietary viral challenge agents, and comprehensive laboratory services, hVIVO supports a global client base of pharmaceutical and biotechnology companies in fast-tracking the development of their products.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for HVIVO PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-29 08:00
Board/Management Information
Proposed appointment of Chair
English 16.3 KB
2025-07-22 08:00
Earnings Release
H1 Trading update
English 26.7 KB
2025-07-18 08:00
Board/Management Information
Directorate Change
English 16.4 KB
2025-07-09 08:00
Report Publication Announcement
Notice of Trading Update
English 17.4 KB
2025-07-01 17:04
Major Shareholding Notification
Holding(s) in Company
English 24.3 KB
2025-06-30 08:00
Earnings Release
Positive results from client Phase 2b field study
English 22.0 KB
2025-06-05 14:00
Post-Annual General Meeting Information
Result of AGM
English 15.3 KB
2025-06-02 08:00
Director's Dealing
Director/PDMR Shareholding
English 48.9 KB
2025-05-30 08:00
Business and Financial Review
Trading update
English 18.7 KB
2025-05-29 08:00
Board/Management Information
Appointment of Independent Non-Executive Director
English 22.6 KB
2025-03-26 14:51
Board/Management Information
AIM Rule 17 and Schedule 2(g) Update
English 15.3 KB
2025-03-07 08:00
Director's Dealing
Director/PDMR Shareholding
English 40.4 KB
2025-02-27 08:00
M&A Activity
Acquisition of Cryostore for up to £3.2m
English 22.4 KB
2025-02-17 08:00
Earnings Release
£2m hMPV characterisation study contract
English 19.3 KB
2025-02-05 08:00
Legal Proceedings Report
Shionogi reports positive RSV trial results
English 19.3 KB

Automate Your Workflow. Get a real-time feed of all HVIVO PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HVIVO PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
Gabather AB Logo
Clinical-stage pharma developing GABAA therapeutics for neuropsychiatric disorders.
Sweden GABA
GEIGER COUNTER LIMITED Logo Jersey GCL
Geneuro Logo
Develops HERV-targeting treatments for neurodegenerative and autoimmune diseases.
Switzerland GEM
GENFIT Logo
Biopharma firm developing therapies & diagnostics for rare and severe liver diseases.
France GNFT
GENFLOW BIOSCIENCES PLC Logo
Developing gene therapies to target the aging process in humans and dogs.
United Kingdom GENF